Results 281 to 287 of about 459,655 (287)

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Allergy: European Journal of Allergy and Clinical Immunology, 2005
Richard Beasley
exaly  

Severe malaria is associated with parasite binding to endothelial protein C receptor

Nature, 2013
Louise Turner, Thomas Lavstsen, Christian W Wang   +2 more
exaly  

Genome sequencing identifies major causes of severe intellectual disability

Nature, 2014
Christian Gilissen, Jayne Y Hehir-kwa, Marjolein H Willemsen   +2 more
exaly  

Population Burden of Long‐Term Survivorship After Severe Sepsis in Older Americans

Journal of the American Geriatrics Society, 2012
Theodore J Iwashyna, Colin R Cooke, Jeremy M Kahn   +2 more
exaly  

Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma

Immunological Reviews, 2017
Philip M Hansbro, Richard Y Kim, Malcolm R Starkey   +2 more
exaly  

Improving State Pain Policies: Recent Progress and Continuing Opportunities

Ca-A Cancer Journal for Clinicians, 2007
exaly  

New treatments for smoking cessation

Ca-A Cancer Journal for Clinicians, 2000
exaly